Small molecules in the race of COVID-19 drug development.

Jash, Rajiv; Prasanth, D S N B K; Jash, Moumita; Suneetha, Achanti

Jash, Rajiv; Prasanth, D S N B K; Jash, Moumita; Suneetha, Achanti.

Afiliação

Jash R; Department of Pharmacy, Sanaka Educational Trust Group of Institutions, Durgapur, West Bengal 713 212, India.
Prasanth DSNBK; Department of Pharmacognosy, KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada, Andhra Pradesh 520 010, India.
Jash M; Department of Pharmacy, Sanaka Educational Trust Group of Institutions, Durgapur, West Bengal 713 212, India.
Suneetha A; Department of Bioscience and Bioengineering, Indian Institute of Technology, Jodhpur, Rajasthan 342037, India.

J Asian Nat Prod Res ; 25(12): 1133-1154, 2023 Dec.

Article em En | MEDLINE | ID: mdl-37066495

Assuntos

COVID-19; Humanos; SARS-CoV-2; Desenvolvimento de Medicamentos; Antivirais/farmacologia

Palavras-chave

Azvudine; COVID-19; MPro Inhibitors; Nirmatrelvir; Remdesivir

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Aspecto: Determinantes_sociais_saude Limite: Humans Idioma: En Revista: J Asian Nat Prod Res Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google